Sanxin Medical announced that the company and its holding subsidiary Ningbo Filar recently obtained the “Medical Device Registration Certificate” issued by the State Drug Administration respectively. Among them, Sanxin Medical obtained a hemodialysis filter registration certificate, which is valid from November 21, 2024 to November 20, 2029. The hemodialysis filter that has obtained the registration certificate this time consists of a blood cap, shell, sealing gel, membrane, and cap, and is suitable for hemodialysis and hemodialysis filtration treatment for patients with acute or chronic renal failure. The product uses a high-throughput dialysis membrane to remove solutes through two mechanisms of dispersion and convection, which can more efficiently remove small molecules and medium to large molecular substances/toxins accumulated in the blood, effectively improving the quality of life of patients. The acquisition of this registration certificate has enriched the company's product chain in the field of blood purification, which is conducive to improving the company's overall competitiveness and will have a positive impact on the company's future operations.